Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Center for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA.
Nat Genet. 2024 Sep;56(9):1832-1840. doi: 10.1038/s41588-024-01884-7. Epub 2024 Aug 27.
Telomeres protect chromosome ends from damage and their length is linked with human disease and aging. We developed a joint telomere length metric, combining quantitative PCR and whole-genome sequencing measurements from 462,666 UK Biobank participants. This metric increased SNP heritability, suggesting that it better captures genetic regulation of telomere length. Exome-wide rare-variant and gene-level collapsing association studies identified 64 variants and 30 genes significantly associated with telomere length, including allelic series in ACD and RTEL1. Notably, 16% of these genes are known drivers of clonal hematopoiesis-an age-related somatic mosaicism associated with myeloid cancers and several nonmalignant diseases. Somatic variant analyses revealed gene-specific associations with telomere length, including lengthened telomeres in individuals with large SRSF2-mutant clones, compared with shortened telomeres in individuals with clonal expansions driven by other genes. Collectively, our findings demonstrate the impact of rare variants on telomere length, with larger effects observed among genes also associated with clonal hematopoiesis.
端粒保护染色体末端免受损伤,其长度与人类疾病和衰老有关。我们开发了一种联合端粒长度指标,结合了来自 462666 名英国生物银行参与者的定量 PCR 和全基因组测序测量结果。该指标增加了 SNP 的遗传力,表明它更好地捕捉了端粒长度的遗传调控。外显子范围罕见变异和基因水平的连锁关联研究确定了 64 个变体和 30 个与端粒长度显著相关的基因,包括 ACD 和 RTEL1 中的等位基因系列。值得注意的是,这些基因中有 16%是克隆性造血的已知驱动基因,这是一种与骨髓癌和几种非恶性疾病相关的与年龄相关的体细胞镶嵌现象。体细胞变异分析揭示了基因与端粒长度的特异性关联,包括与其他基因驱动的克隆扩张相比,具有较大 SRSF2 突变克隆的个体的端粒延长。总的来说,我们的研究结果表明,罕见变异对端粒长度有影响,在与克隆性造血相关的基因中观察到更大的影响。